|Title:||10-YEAR RETROSPECTIVE DATA ON NON-SMALL CELL LUNG CANCER (NSCLC): NO IMPROVEMENT IN EARLY DETECTION|
|Author(s):||SW. Tio A. O’Mahony P. Coghlan D. Curran TM. O’Connor|
|Institution:||Mercy University Hospital|
|Poster:||Click to view poster|
|Category:||Lung Cancer and Bronchoscopy|
|Abstract:||We analyzed data over a 10-year period (2010-2020) of patients with lung cancer diagnosed in the Mercy University Hospital (MUH) to determine whether there is improvement in early detection of non-small cell lung cancer (NSCLC). |
NSCLC remains the most common type of lung cancer presentation in MUH, accounting for 602 (59%) of 1027 cases. The sex ratio was 1.5 male to female, but mean age at diagnosis was comparable at 66 years. The majority of NSCLC were diagnosed at later stages - 272 (45%) at Stage 4 and 144 (24%) at Stage 3. The remaining 55 (9%), 95 (16%) and 36 (6%) were Stage 2, Stage 1 and unknown respectively.
Looking in more depth at those diagnosed in Stage 4, the percentage of patients diagnosed at late stage remained constant throughout the 10-year interval, varying from 40% - 60%.
Data collected from our institution were consistent with national data from 2012-2014, which showed most lung cancer was diagnosed at Stage 4 (40%) and Stage 3 (25%). These results reflect that the last five years did not show significant improvements in detecting NSCLC at an earlier stage. These data support the case for lung cancer screening in Ireland.